TM Bioscience signs distribution agreement with Gamidor in Israel
"Gamidor, like Tm, is committed to providing its customers with the most advanced and accurate diagnostic technology available," said Greg Hines, President and CEO of Tm Bioscience. "They are the ideal partners to enable Tm to penetrate a major market for our products beyond North America." Gamidor distributes products in Israel for the world's largest suppliers of clinical diagnostics, including Perkin Elmer Life Sciences and Dade Behring.
"The market for genetic tests is well established in Israel and we anticipate tests from Tm, in particular their Cystic Fibrosis gene test and Ashkenazi Jewish Panel, will be well received," said Yacob Ofer, CEO of Gamidor Diagnostics. "These will be important products to showcase Gamidor's leadership role as a provider of cutting edge diagnostic products."
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.